Characteristics | Candida | Crude-OR (95.0% CI) | Adjusted-OR (95.0% CI) | |||
---|---|---|---|---|---|---|
Positive | Negative | Total | OR (Lower-Upper) | OR (Lower-Upper) | p-value | |
18–25 | 35(18%) | 159(82%) | 194(50.5%) | 1 |  |  |
26–33 | 51(31.1%) | 113(68.9%) | 164(42.7%) | 2.050(1.25–3.35) | 1.89(1.02–3.49) | .041 |
34–40 | 10(38.5%) | 16(61.5%) | 26(6.8%) | 2.839(1.18–6.78) | 2.27(1.01–7.30) | .046 |
Symptom | ||||||
 Symptomatic | 46(40.5%) | 67(59.3%) | 113(29.4%) | 3.035(1.86–4.92) | 2.69(1.60–4.52) | <.001 |
 Asymptomatic | 50(18.7%) | 221(81.5%) | 271(70.6%) | 1 |  |  |
antibiotic use | ||||||
 No | 68(21%) | 256(79%) | 324(84.4) | 1 |  |  |
 Yes | 28(46.7%) | 32(53.3) | 60(15.6%) | .034 (0.17–0.53) | .393(0.21–0.72) | .003 |
Contraceptive use | ||||||
 No | 15(12.8%) | 102(87.2%) | 117(30.5%) | 1 |  |  |
 Yes | 81(30.3%) | 186(69.7%) | 267(69.5%) | .338 (0.18–61) | .394(0.20–0.74) | .004 |
Gravidity | ||||||
 Primigravida | 36(20.1%) | 143(79.9%) | 179(46.6%) | 1 |  |  |
 Multigravida | 60(29.3%) | 145(70.7%) | 205(53.4%) | .608(0.37–0.97) | .909(0.49–1.67) | .758 |
HIV status | ||||||
 Negative | 82(23.8%) | 262(76.2%) | 344(89.6%) | 1 |  |  |
 Positive | 14(35%) | 26(65%) | 40(10.4%) | 1.720(.85–3.44) | .629(.54–2.71) | .629 |
Gestational period | ||||||
 1st trimester | 9(23.1%) | 30(76.9%) | 39(10.2%) | 1 |  |  |
 2nd trimester | 32(23.7%) | 103(76.3%) | 135(35.2%) | 1.036(.44–2.40) | .937(.37–2.35) | .890 |
 3rd trimester | 55(26.2%) | 155(75%) | 210(54.7%) | 1.183(.52–2.64) | 1.040(.43–2.50) | .930 |